Stocks

Boralex's Future in Focus: Brookfield's Take-Private Offer Aligns with Analysts' Valuations

By Qayyum Rajan, CFA -
Stocks & ETFs:BAM.TO
Photos provided by Pexels

Boralex's stock price is now closely tied to Brookfield's proposed take-private offer of CA$37.25, with analysts adjusting their price targets accordingly. This alignment raises questions about the company's growth prospects post-transaction.

As Boralex moves closer to being taken private by Brookfield Renewables, its share price has stabilized around the proposed offer of CA$37.25. Analysts are responding with revised price targets, reflecting a cautious optimism about the deal while also highlighting potential limitations on future growth beyond the acquisition. With a fair value estimate of CA$36.88, the market is weighing the implications of this significant transaction for Canadian investors.

Investor takeaway: Long-term holders should consider how the Brookfield deal may reshape Boralex's growth trajectory and market positioning.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Brookfield Asset Management Ltd

BAM.TO

Full stock page โ†’

BAM.TO

Brookfield Asset Management Ltd

Source:WealthAwesomeWealthAwesome
โ†“ $3.62 (-5.18%)
120 day period
$58.76$65.24$71.72Jan 20Apr 16Jul 10

Market cap

$105.71B

P/E

29.8x

52W high

$84.98

52W low

$57.50

1W change

+0.68%

Beta

1.26

Analyst Price Targets

Based on analyst covering BAM

๐Ÿ“ˆ

Wall Street analysts forecast BAM stock price to rise 22.0% over the next 12 months.

Consensus

No Rating

Avg. Target

C$80.76

+22.0% Upside

Current Price

C$66.20

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BAM's historical volatility

HistoricalForecast68%95%
C$43.41C$54.11C$64.81C$75.50C$86.20C$96.89TodayMar 4May 7Jul 10Aug 22Oct 5Nov 17

30-Day Vol

31.1%

Annualized

90-Day Vol

27.5%

Annualized

Trend (90d)

-5.6%

Annualized drift

90d Mean

C$64.89

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$65.76C$59.07 โ€“ C$73.20
60 trading daysC$65.32C$56.13 โ€“ C$76.02
90 trading daysC$64.89C$53.89 โ€“ C$78.13

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

How the Proposed Acquisition Shapes Boralex's Valuation

Boralex's fair value estimate remains stable at CA$36.88, with revenue growth expectations at 4.98% and a net profit margin of 34.60%. This stability amidst the acquisition discussions suggests that while the deal is seen as a fair valuation, future growth may be constrained, impacting long-term investor sentiment.

Bull case

  • Analysts from RBC Capital and Scotiabank are raising their price targets, showing confidence in the valuation implied by the Brookfield offer.
  • The alignment of multiple firms around the CA$37.25 level indicates a consensus that the take-private transaction is a fair reflection of Boralex's value.

Bear case

  • Raymond James has downgraded Boralex to Market Perform, indicating limited upside potential beyond the acquisition price.
  • Concerns over execution and growth options after the transaction are leading some analysts to take a more cautious stance.

Analysts Weigh In on Boralex's Valuation

RBC Capital and Scotiabank's bullish outlook reflects confidence in the proposed acquisition's valuation, suggesting that the CA$37.25 offer by Brookfield is a reasonable anchor for Boralex's stock price. This alignment among analysts indicates a strong consensus on the stock's current value amidst the ongoing deal discussions.

Cautious Sentiment from Raymond James

Despite the bullish sentiment from some analysts, Raymond James has taken a more cautious approach, downgrading Boralex to Market Perform and setting a price target at CA$37.25. This move highlights concerns over the limited upside potential and questions about the company's growth trajectory following the acquisition.

The Future of Boralex Post-Acquisition

As the acquisition progresses, Boralex's future growth potential remains a key focus for investors. With a significant project pipeline and the growing demand for clean energy, the company may face challenges such as rising debt and competition for long-term contracts. Investors will need to monitor how these factors play out in the context of the Brookfield deal.

Advertisement

Sponsored links

Advertisement